Back to Search Start Over

Policy Recommendations for Pharmacy Benefit Managers to Stem the Escalating Costs of Prescription Drugs: A Position Paper From the American College of Physicians.

Authors :
Daniel H
Bornstein SS
Source :
Annals of internal medicine [Ann Intern Med] 2019 Dec 03; Vol. 171 (11), pp. 823-824. Date of Electronic Publication: 2019 Nov 12.
Publication Year :
2019

Abstract

Recent discussions about the increasing prices of prescription drugs have focused on pharmacy benefit managers (PBMs), third-party intermediaries for various types of employers and government purchasers who negotiate drug prices in health plans and thus play a crucial role in determining the amount millions of Americans pay for medications. In this position paper, the American College of Physicians expands on its position paper from 2016 by offering additional recommendations to improve transparency in the PBM industry and highlighting the need for reliable, timely, and relevant information on prescription drug pricing for physicians and patients.

Details

Language :
English
ISSN :
1539-3704
Volume :
171
Issue :
11
Database :
MEDLINE
Journal :
Annals of internal medicine
Publication Type :
Academic Journal
Accession number :
31711103
Full Text :
https://doi.org/10.7326/M19-0035